P. Cullis
Molecular Biology · 2004–2021
A researcher in the Science corpus: 8 papers; trusts 3 researchers and is trusted by 15 researchers here, as inferred from the citation graph.
Subfields
- Molecular Biology — 67 citations into it; #4,045 of 17,773 by trust here, #2,189 by citations
- Biomaterials — 14 citations into it; #351 of 2,152 by trust here, #489 by citations
- Biomedical Engineering — 13 citations into it
Whom P. Cullis trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts P. Cullis overall
Papers from P. Cullis's perspective
Ordered by how strongly the researchers P. Cullis trusts endorse each paper. Same corpus, a different order for every researcher.
- Drug Delivery Systems: Entering the Mainstream (Science)
- A combinatorial library of lipid-like materials for delivery of RNAi therapeutics (Nature Biotechnology)
- Delivering nanomedicine to solid tumors (Nature Reviews Clinical Oncology)
- Antibody targeting of long-circulating lipidic nanoparticles does not increase tumor localization but does increase internalization in animal models. (Cancer Research)
- Ligand-targeted therapeutics in anticancer therapy (Nature Reviews. Cancer)
- Therapeutic RNAi targeting PCSK9 acutely lowers plasma cholesterol in rodents and LDL cholesterol in nonhuman primates (Proceedings of the National Academy of Sciences of the United States of America)
- TAT peptide on the surface of liposomes affords their efficient intracellular delivery even at low temperature and in the presence of metabolic inhibitors (Proceedings of the National Academy of Sciences of the United States of America)
- Anti-HER2 immunoliposomes: enhanced efficacy attributable to targeted delivery. (Clinical Cancer Research)
- Toxicity of cationic lipids and cationic polymers in gene delivery. (Journal of Controlled Release)
- Zika virus protection by a single low dose nucleoside modified mRNA vaccination (Nature)
Their papers
- Drug Delivery Systems: Entering the Mainstream (2004) — 4,318 citations
- Microfluidic Synthesis of Highly Potent Limit-size Lipid Nanoparticles for In Vivo Delivery of siRNA (2012) — 615 citations
- Maximizing the Potency of siRNA Lipid Nanoparticles for Hepatic Gene Silencing In Vivo (2012) — 1,185 citations
- Rational design of cationic lipids for siRNA delivery (2010) — 1,657 citations
- Liposomal drug delivery systems: from concept to clinical applications. (2013) — 4,362 citations
- The Onpattro story and the clinical translation of nanomedicines containing nucleic acid-based drugs (2019) — 1,342 citations
- The current landscape of nucleic acid therapeutics (2021) — 1,072 citations
- Lipid Nanoparticle Systems for Enabling Gene Therapies. (2017) — 1,006 citations